Dehui Zou
机构:Chinese Academy of Medical Sciences & Peking Union Medical College, National Clinical Research, Institute of Hematology & Blood Diseases Hospital · ORCID:0000-0002-8135-4913
发表论文 503 篇 · 总被引 3361 次 · h-index 30
代表论文
- Phase 2 study of relmacabtagene autoleucel (CD19 CAR-T) for relapsed/refractory mantle cell lymphoma in Chinese adults (2025 · Blood Advances · 被引 5)
- Type I Interferon Pathway Activation Disrupts Monocyte Maturation and Enhances Immune Evasion in Multiple Myeloma (2025 · Advanced Science · 被引 1)
- SOUNDTRACK-F1: A phase 3, randomized, open-label study of surovatamig (AZD0486) plus rituximab versus chemotherapy plus rituximab in patients with previously untreated follicular lymphoma (2025 · Blood · 被引 1)
- Effect of bone marrow mononuclear cells therapy on long-term survival of patients with liver cirrhosis: A 10-year retrospective cohort study using propensity score matching (2025 · Journal of Translational Internal Medicine · 被引 1)
- Two‐year follow‐up of relmacabtagene autoleucel in relapsed or refractory follicular lymphoma in RELIANCE study (2025 · British Journal of Haematology · 被引 1)
- Identification of a CAR‐Derived Clone by NGS ‐Based MRD After Fully Human BCMA CAR T‐Cell Therapy in Multiple Myeloma (2025 · American Journal of Hematology · 被引 1)